Terms: = Brain cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Clinical Outcome
49 results:
1. Microsurgical removal of supratentorial and cerebellar cavernous malformations: what has changed? A single institution experience.
Meneghelli P; Pasqualin A; Musumeci A; Pinna G; Berti PP; Polizzi GMV; Sinosi FA; Nicolato A; Sala F
J Clin Neurosci; 2024 May; 123():162-170. PubMed ID: 38581776
[TBL] [Abstract] [Full Text] [Related]
2. Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype.
Ren L; Hua L; Bao Z; Deng J; Wang D; Chen J; Chen H; Juratli TA; Wakimoto H; Gong Y
J Neurooncol; 2023 Jan; 161(2):193-202. PubMed ID: 35612696
[TBL] [Abstract] [Full Text] [Related]
3. Mini-craniotomy for intra-axial brain tumors: a comparison with conventional craniotomy in 306 patients harboring non-dural based lesions.
Paolini S; Severino R; Mancarella C; Cardarelli G; Ciavarro M; Di Castelnuovo A; Iacoviello L; Minniti G
Neurosurg Rev; 2022 Aug; 45(4):2983-2991. PubMed ID: 35585468
[TBL] [Abstract] [Full Text] [Related]
4. Thymic Lesions in Myasthenia Gravis: A Clinicopathological Study from India.
Nishadham V; Bardhan M; Polavarapu K; Vengalil S; Nashi S; Menon D; Ganaraja VH; Preethish-Kumar V; Valasani RK; Huddar A; Unnikrishnan GK; Thomas A; Saravanan A; Kulanthaivelu K; Nalini A; Nandeesh BN
J Neuromuscul Dis; 2022; 9(3):411-422. PubMed ID: 35431258
[TBL] [Abstract] [Full Text] [Related]
5. Molecular subgrouping of ependymoma across three anatomic sites and their prognostic implications.
Chinnam D; Gupta K; Kiran T; Saraswati A; Salunke P; Madan R; Kumar N; Radotra BD
Brain Tumor Pathol; 2022 Jul; 39(3):151-161. PubMed ID: 35348910
[TBL] [Abstract] [Full Text] [Related]
6. Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancer.
Nguyen HG; Lundström O; Blank A; Dawson H; Lugli A; Anisimova M; Zlobec I
Mod Pathol; 2022 Feb; 35(2):240-248. PubMed ID: 34475526
[TBL] [Abstract] [Full Text] [Related]
7. Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study.
Wagner NB; Lenders MM; Kühl K; Reinhardt L; André F; Dudda M; Ring N; Ebel C; Stäger R; Zellweger C; Lang R; Paar M; Gussek P; Richtig G; Stürmer SH; Kimeswenger S; Oellinger A; Forschner A; Leiter U; Weide B; Gassenmaier M; Schraag A; Klumpp B; Hoetzenecker W; Berking C; Richtig E; Ziemer M; Mangana J; Terheyden P; Loquai C; Nguyen VA; Gebhardt C; Meier F; Diem S; Cozzio A; Flatz L; Röcken M; Garbe C; Eigentler TK
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33986126
[TBL] [Abstract] [Full Text] [Related]
8. clinical outcome after CyberKnife® radiosurgery re-irradiation for recurrent brain metastases.
Berber T; Raturi V; Aksaray F; Hojo H; Fujisawa T; Ohyoshi H
Cancer Radiother; 2021 Jul; 25(5):457-462. PubMed ID: 33752961
[TBL] [Abstract] [Full Text] [Related]
9. Local Control After Proton Therapy for Pediatric Chordoma.
Indelicato DJ; Rotondo RL; Mailhot Vega RB; Holtzman AL; Looi WS; Morris CG; Sandler ES; Aldana PR; Bradley JA
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1406-1413. PubMed ID: 33253819
[TBL] [Abstract] [Full Text] [Related]
10. [
Rani N; Singh B; Kumar N; Singh P; Hazari PP; Vyas S; Hooda M; Chitkara A; Shekhawat AS; Gupta SK; Radotra BD; Mishra AK
Cancer Biother Radiopharm; 2021 Sep; 36(7):568-578. PubMed ID: 32644819
[No Abstract] [Full Text] [Related]
11. Risks and Benefits of Glioblastoma Resection in Older Adults: A Retrospective Austrian Multicenter Study.
Schwartz C; Romagna A; Stefanits H; Zimmermann G; Ladisich B; Geiger P; Rechberger J; Winkler S; Weiss L; Fastner G; Trinka E; Weis S; Spiegl-Kreinecker S; Steinbacher J; McCoy M; Johannes T; Gruber A; Rezai Jahromi B; Niemelä M; Winkler PA; Thon N
World Neurosurg; 2020 Jan; 133():e583-e591. PubMed ID: 31561040
[TBL] [Abstract] [Full Text] [Related]
12. outcomes Following Proton Therapy for Pediatric Low-Grade Glioma.
Indelicato DJ; Rotondo RL; Uezono H; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Bradley JA
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):149-156. PubMed ID: 30684665
[TBL] [Abstract] [Full Text] [Related]
13. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
González I; Goyal B; Xia MD; Pai RK; Ma C
Hum Pathol; 2019 Mar; 85():18-26. PubMed ID: 30381262
[TBL] [Abstract] [Full Text] [Related]
14. Gamma knife radiosurgery for recurrent gliomas.
Sadik ZHA; Hanssens PEJ; Verheul JB; Beute GN; Te Lie S; Leenstra S; Ardon H
J Neurooncol; 2018 Dec; 140(3):615-622. PubMed ID: 30191361
[TBL] [Abstract] [Full Text] [Related]
15. Primary Solitary Intracranial Malignant Melanoma: A Systematic Review of Literature.
Arai N; Kagami H; Mine Y; Ishii T; Inaba M
World Neurosurg; 2018 Sep; 117():386-393. PubMed ID: 29959081
[TBL] [Abstract] [Full Text] [Related]
16. clinical outcome and prognostic analysis of meningeal carcinomatosis treated by intrathecal chemotherapy.
Meng Z; Zhang Q; Hong K; Han W; Zhao Z; Liu Y; He J; Bu H
Expert Rev Pharmacoecon Outcomes Res; 2018 Aug; 18(4):455-460. PubMed ID: 29745736
[TBL] [Abstract] [Full Text] [Related]
17. Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
Eur Radiol; 2018 Sep; 28(9):3819-3831. PubMed ID: 29619517
[TBL] [Abstract] [Full Text] [Related]
18. Is Fractionated Gamma Knife Radiosurgery a Safe and Effective Treatment Approach for Large-Volume (>10 cm
Han MS; Jang WY; Moon KS; Lim SH; Kim IY; Jung TY; Jung S
World Neurosurg; 2017 Mar; 99():477-483. PubMed ID: 28017757
[TBL] [Abstract] [Full Text] [Related]
19. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast cancer.
Cardoso F; van't Veer LJ; Bogaerts J; Slaets L; Viale G; Delaloge S; Pierga JY; Brain E; Causeret S; DeLorenzi M; Glas AM; Golfinopoulos V; Goulioti T; Knox S; Matos E; Meulemans B; Neijenhuis PA; Nitz U; Passalacqua R; Ravdin P; Rubio IT; Saghatchian M; Smilde TJ; Sotiriou C; Stork L; Straehle C; Thomas G; Thompson AM; van der Hoeven JM; Vuylsteke P; Bernards R; Tryfonidis K; Rutgers E; Piccart M;
N Engl J Med; 2016 Aug; 375(8):717-29. PubMed ID: 27557300
[TBL] [Abstract] [Full Text] [Related]
20. Assessment of radiobiological metrics applied to patient-specific QA process of VMAT prostate treatments.
Clemente-Gutiérrez F; Pérez-Vara C; Clavo-Herranz MH; López-Carrizosa C; Pérez-Regadera J; Ibáñez-Villoslada C
J Appl Clin Med Phys; 2016 Mar; 17(2):341-367. PubMed ID: 27074458
[TBL] [Abstract] [Full Text] [Related]
[Next]
